Ubretid (Standard)
Ubretid (Standard) is the analytical standard of Ubretid. This product is intended for research and analytical applications. Ubretid is a potent inhibitor of plasma cholinesterase. Ubretid therefore delays the hydrolysis of suxamethonium and prolongs its action, similar to the effects shown by other anticholinesterase agents, such as pyridostigmine and donepezil. Ubretid has the potential for the research of urinary retention prolongs the effect of suxamethonium. Ubretid is commonly prescribed for the research of myasthenia gravis and for difficulty in emptying the bladder[1].
Product Specifications
CAS Number
15876-67-2
Product Name Alternative
Distigmine (dibromide) (Standard)
UNSPSC
12352005
Target
Cholinesterase (ChE) ; Reference Standards
Type
Reference Standards
Related Pathways
Neuronal Signaling; Others
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ubretid-standard.html
Smiles
O=C(N(C)CCCCCCN(C)C(OC1=C[N+](C)=CC=C1)=O)OC2=C[N+](C)=CC=C2.[Br-].[Br-]
Molecular Formula
C22H32Br2N4O4
Molecular Weight
576.32
References & Citations
[1]Isono S, et al. Ubretid (distigmine bromide) taken to treat urinary retention prolongs the effect of suxamethonium. J Anesth. 2008;22 (3) :337.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Phosphoglycerate Mutase 1, Brain (PGAM1) ELISA Kit
